Arkolith/Insider Trading/TERN/Form 4

Kuriakose Emil

Chief Medical OfficerTerns Pharmaceuticals, Inc. (TERN) · full profile →Form 4 · filed May 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2026Tender(U)25K$53.00$1.3M0
May 5, 2026Disposed to issuer(D)82K$53.00$4.3M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2026Disposed to issuer(D)485K——0
May 5, 2026Disposed to issuer(D)118K——0
May 5, 2026Disposed to issuer(D)120K——0
May 5, 2026Disposed to issuer(D)280K——0
May 5, 2026Disposed to issuer(D)113K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001892413-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML